Glimepiride (2mg) & Metformin Hydrochloride (500mg) Prolonged Release, marketed as GLIMITERIS M2, is a combination medication used to manage type 2 diabetes. This formulation offers the benefits of both drugs, providing an effective solution for patients who require both insulin release stimulation and glucose production control.

How Does It Work?

Glimepiride:

• Stimulates insulin release from pancreatic beta cells.
• Enhances peripheral insulin sensitivity.

Metformin Hydrochloride:

• Decreases hepatic glucose production.
• Improves insulin sensitivity and glucose uptake in muscles.

Uses of GLIMITERIS M2

• Blood Sugar Control: Helps lower blood glucose levels in adults with type 2 diabetes.
• Combination Therapy: Effective for patients who need both Glimepiride and Metformin.
• Extended Release: Ensures prolonged action, reducing the frequency of dosage.

What is GLIMITERIS M2?

GLIMITERIS M2 is an oral diabetes medication combining Glimepiride and Metformin Hydrochloride in a prolonged-release form. It aids in managing blood sugar levels by targeting different mechanisms involved in glucose regulation.

Side Effects

• Common Side Effects: Nausea, vomiting, stomach upset, diarrhea, and dizziness.
• Serious Side Effects: Hypoglycemia (low blood sugar), lactic acidosis (rare but serious), and allergic reactions.

Safety Information

• Monitoring: Regular blood sugar monitoring is essential.
• Diet and Exercise: Adhere to a proper diet and exercise regimen.
• Alcohol: Limit alcohol consumption to avoid interactions and side effects.
• Kidney Function: Not recommended for patients with severe renal impairment.

If You Need More Information About GLIMITERIS M2  Click here